Common Stock |
9 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2026 | ||||
| Common Stock [Abstract] | ||||
| COMMON STOCK |
Nine Months Ended March 31, 2026
On June 3, 2024, the Company entered into a purchase agreement with an investor for the sale of up to $50,000,000 of shares of common stock. For the nine months ended March 31, 2026, the Company issued 36,914,063 shares of common stock for $750,000 under the purchase agreement at prices of $0.01948 - $0.02000, pursuant to purchase notices received from the investor. The finance cost of $18,123 was deducted from the gross proceeds received, leaving net proceeds of $731,877.
On March 12, 2026, the Company issued 252,631,579 shares of common stock, upon conversion of 2,400 shares of preferred stock with a stated value of $240,000 at a conversion price of $0.00095. Nine Months Ended March 31, 2025
On November 11, 2022, the Company entered into a purchase agreement with an investor for the sale of up to $45,000,000 of shares of common stock. For the nine months ended March 31, 2025, the Company issued 118,513,734 shares of common stock for $2,250,000 under the purchase agreement at prices of $0.0156 - $0.02024, pursuant to purchase notices received from the investor. The finance cost of $48,075 was deducted from the gross proceeds received, leaving net proceeds of $2,201,925.
On November 22, 2024, the Company issued 231,578,947 shares of common stock, upon conversion of 2,200 shares of preferred stock with a stated value of $220,000 at a conversion price of $0.00095. |